Both assays showed that YC wax NP bound gp140 with high efficiency (Fig. 1D and E). Binding

of BSA Veliparib in vitro and TT to wax NP, assessed by Bradford, was also highly efficient (data not shown). In vitro human monocyte-derived DC were generated using a standardized protocol as described by Henderson et al. [26] with minor modifications. Blood-derived monocytes were isolated by plastic adherence and showed typical spiky cell membrane projections following 7 days of culture in the presence of GM-CSF and IL-4, as shown in Fig. 2A. Immunostaining and flow cytometry analysis of 11 different DC isolations showed that 91.6% ± 3.8 (range: 84.7–96.6%) of cells had a DC phenotype with very low or negative expression of CD14, and high expression of CD11c,

HLA-class II Ags, and DC-SIGN. CD40 and CX-5461 clinical trial CD86 were consistently highly expressed on these cells, whereas CD80 and the maturation marker CD83 were expressed at low levels (Fig. 2B). The non-DC present in these isolates were consistently B-lymphocytes (Fig. 2B inset). The three YC-wax NP were studied for NP intracellular uptake. Both naked and TT- and gp140-adsorbed YC NP were readily internalized by DC as demonstrated by flow cytometry and confocal microscopy (Fig. 2C and D, respectively). Once internalized, YC NP were localized in endolysosomes (Fig. 2E). Cellular uptake of YC-wax NP was more efficient and was more uniformly distributed within the cell population than that of polystyrene nanobeads (Fig. 2F). Here, 100% of THP-1 cells internalized YC-wax NP whereas about 70–90% of these cells internalized polystyrene NP. Human monocyte-derived DC were stimulated with gp140-adsorbed YC-wax NP (YC-SDS, YC-NaMA, and YC-Brij700-chitosan) and expression of the for cell surface markers CD40, CD54, CD80, CD83, CD86, CCR7, and HLA-class II Ags was assessed by immunofluorescence and flow cytometry after 24, 48, and 72 h post-stimulation. There was no effect on the expression of these molecules, even when tested at an extended time point

of 72 h (data not shown). Likewise, there was no cytokine/chemokine induction by YC-wax-gp140-adsorbed NP (data not shown). Naked NP also did not induce any DC activation. We sought to determine whether YC-wax NP would enhance the T-cell proliferation responses to Ag. Since there are some limitations for the use of gp140 to induce human T-cell proliferation in vitro such as the lack of immune response in HIV unexposed healthy volunteers, and the anergic status of many HIV-infected individuals, TT was used as a model Ag. Hence, we tested the capacity of TT-adsorbed YC-wax NP to enhance T-cell proliferation in fresh PBMC from healthy volunteers. As shown in Fig. 3A, YC-wax NP enhanced T-cell proliferation to TT. This response was independent of the type of particles since both negatively (YC-wax SDS and YC-wax NaMA) and positively (YC-wax Brij700-chitosan) charged NP enhanced T-cell proliferation responses to TT (P < 0.0001).